IMVARIA Inc.
PrivateLast Round
Early Funding
Jan 7, 2026
Momentum Score
75 /100
Company Overview
IMVARIA Inc. is a healthcare technology company founded in 2019 that specializes in developing artificial intelligence-driven digital biomarker solutions. The company's platforms, including the FDA-authorized Fibresolve and FDA-cleared ScreenDx, analyze clinical imaging and lab data to help clinicians diagnose and assess complex conditions, particularly interstitial lung diseases (ILD) and idiopathic pulmonary fibrosis (IPF), at earlier stages and without the need for invasive procedures. Based in Berkeley, California, the company was founded by physician-engineers from Google and Stanford University. IMVARIA has received funding from investors like Mayo Clinic Ventures and UCSF Rosenman Institute, as well as a Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) to expand its technology into oncology.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IMVARIA Inc. Comps
Public and private peers based on sector, stage, and business model.
IMVARIA Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jan 7, 2026 | ||||
| Grant | Sep 3, 2025 | ||||
| Accelerator | Jun 15, 2021 | ||||
| Accelerator | Jun 10, 2021 |
Key People
Founding team and executive leadership
IMVARIA Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UCSF Rosenman Institute | Accelerator |
| MedTech Innovator | Accelerator |
| NIH RADx | Grant |
| Inhealth Ventures | Early Funding |
| Labcorp Venture Fund | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2025
Presented AI diagnostic referral service results at ATS 2025.
IMVARIA Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about IMVARIA Inc.'s valuation, stock price, and market status.
